This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiraha, H.
Right arrow Articles by Wells, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiraha, H.
Right arrow Articles by Wells, A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2002, p. 2716-2727, Vol. 22, No. 8
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.8.2716-2727.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Activation of m-Calpain (Calpain II) by Epidermal Growth Factor Is Limited by Protein Kinase A Phosphorylation of m-Calpain

Hidenori Shiraha,1 Angela Glading,1 Jeffrey Chou,1 Zongchao Jia,2 and Alan Wells1*

Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261,1 Department of Biochemistry, Queen's University, Kingston, Ontario, Canada K7L 3N62

Received 10 July 2001/ Returned for modification 20 August 2001/ Accepted 4 January 2002

We have shown previously that the ELR-negative CXC chemokines interferon-inducible protein 10, monokine induced by gamma interferon, and platelet factor 4 inhibit epidermal growth factor (EGF)-induced m-calpain activation and thereby EGF-induced fibroblast cell motility (H. Shiraha, A. Glading, K. Gupta, and A. Wells, J. Cell Biol. 146:243-253, 1999). However, how this cross attenuation could be accomplished remained unknown since the molecular basis of physiological m-calpain regulation is unknown. As the initial operative attenuation signal from the CXCR3 receptor was cyclic AMP (cAMP), we verified that this second messenger blocked EGF-induced motility of fibroblasts (55% ± 4.5% inhibition) by preventing rear release during active locomotion. EGF-induced calpain activation was inhibited by cAMP activation of protein kinase A (PKA), as the PKA inhibitors H-89 and Rp-8Br-cAMPS abrogated cAMP inhibition of both motility and calpain activation. We hypothesized that PKA might negatively modulate m-calpain in an unexpected manner by directly phosphorylating m-calpain. A mutant human large subunit of m-calpain was genetically engineered to negate a putative PKA consensus sequence in the regulatory domain III (ST369/370AA) and was expressed in NR6WT mouse fibroblasts to represent about 30% of total m-calpain in these cells. This construct was not phosphorylated by PKA in vitro while a wild-type construct was, providing proof of the principle that m-calpain can be directly phosphorylated by PKA at this site. cAMP suppressed EGF-induced calpain activity of cells overexpressing a control wild-type human m-calpain (83% ± 3.7% inhibition) but only marginally suppressed that of cells expressing the PKA-resistant mutant human m-calpain (25% ± 5.5% inhibition). The EGF-induced motility of the cells expressing the PKA-resistant mutant also was not inhibited by cAMP. Structural modeling revealed that new constraints resulting from phosphorylation at serine 369 would restrict domain movement and help "freeze" m-calpain in an inactive state. These data point to a novel mechanism of negative control of calpain activation, direct phosphorylation by PKA.


* Corresponding author. Mailing address: Department of Pathology, University of Pittsburgh, S713 Scaife, Terrace and Lothrop Street, Pittsburgh, PA 15261. Phone: (412) 624-0973. Fax: (412) 647-8567. E-mail: wells{at}msx.upmc.edu.


Molecular and Cellular Biology, April 2002, p. 2716-2727, Vol. 22, No. 8
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.8.2716-2727.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Li, Y., Li, Y., Feng, Q., Arnold, M., Peng, T. (2009). Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. Cardiovasc Res 84: 100-110 [Abstract] [Full Text]  
  • Bodnar, R. J., Yates, C. C., Rodgers, M. E., Du, X., Wells, A. (2009). IP-10 induces dissociation of newly formed blood vessels. J. Cell Sci. 122: 2064-2077 [Abstract] [Full Text]  
  • Okamura, D. M., Pennathur, S., Pasichnyk, K., Lopez-Guisa, J. M., Collins, S., Febbraio, M., Heinecke, J., Eddy, A. A. (2009). CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD. J. Am. Soc. Nephrol. 20: 495-505 [Abstract] [Full Text]  
  • Yates, C. C., Whaley, D., Y-Chen, A., Kulesekaran, P., Hebda, P. A., Wells, A. (2008). ELR-Negative CXC Chemokine CXCL11 (IP-9/I-TAC) Facilitates Dermal and Epidermal Maturation during Wound Repair. Am. J. Pathol. 173: 643-652 [Abstract] [Full Text]  
  • Yates, C. C., Whaley, D., Kulasekeran, P., Hancock, W. W., Lu, B., Bodnar, R., Newsome, J., Hebda, P. A., Wells, A. (2007). Delayed and Deficient Dermal Maturation in Mice Lacking the CXCR3 ELR-Negative CXC Chemokine Receptor. Am. J. Pathol. 171: 484-495 [Abstract] [Full Text]  
  • Nuzzi, P. A., Senetar, M. A., Huttenlocher, A. (2007). Asymmetric Localization of Calpain 2 during Neutrophil Chemotaxis. Mol. Biol. Cell 18: 795-805 [Abstract] [Full Text]  
  • Shao, H., Chou, J., Baty, C. J., Burke, N. A., Watkins, S. C., Stolz, D. B., Wells, A. (2006). Spatial Localization of m-Calpain to the Plasma Membrane by Phosphoinositide Biphosphate Binding during Epidermal Growth Factor Receptor-Mediated Activation.. Mol. Cell. Biol. 26: 5481-5496 [Abstract] [Full Text]  
  • Su, Y., Cui, Z., Li, Z., Block, E. R. (2006). Calpain-2 regulation of VEGF-mediated angiogenesis. FASEB J. 20: 1443-1451 [Abstract] [Full Text]  
  • Marzia, M., Chiusaroli, R., Neff, L., Kim, N.-Y., Chishti, A. H., Baron, R., Horne, W. C. (2006). Calpain Is Required for Normal Osteoclast Function and Is Down-regulated by Calcitonin. J. Biol. Chem. 281: 9745-9754 [Abstract] [Full Text]  
  • Bodnar, R. J., Yates, C. C., Wells, A. (2006). IP-10 Blocks Vascular Endothelial Growth Factor-Induced Endothelial Cell Motility and Tube Formation via Inhibition of Calpain. Circ. Res. 98: 617-625 [Abstract] [Full Text]  
  • Xu, L., Deng, X. (2006). Protein Kinase C{iota} Promotes Nicotine-induced Migration and Invasion of Cancer Cells via Phosphorylation of {micro}- and m-Calpains. J. Biol. Chem. 281: 4457-4466 [Abstract] [Full Text]  
  • Howe, A. K., Baldor, L. C., Hogan, B. P. (2005). Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc. Natl. Acad. Sci. USA 102: 14320-14325 [Abstract] [Full Text]  
  • Franco, S. J., Huttenlocher, A. (2005). Regulating cell migration: calpains make the cut. J. Cell Sci. 118: 3829-3838 [Abstract] [Full Text]  
  • Satish, L., Blair, H. C., Glading, A., Wells, A. (2005). Interferon-Inducible Protein 9 (CXCL11)-Induced Cell Motility in Keratinocytes Requires Calcium Flux-Dependent Activation of {micro}-Calpain. Mol. Cell. Biol. 25: 1922-1941 [Abstract] [Full Text]  
  • Sato, K., Hattori, S., Irie, S., Sorimachi, H., Inomata, M., Kawashima, S. (2004). Degradation of Fodrin by m-Calpain in Fibroblasts Adhering to Fibrillar Collagen I Gel. J Biochem 136: 777-785 [Abstract] [Full Text]  
  • Inserte, J., Garcia-Dorado, D., Ruiz-Meana, M., Agullo, L., Pina, P., Soler-Soler, J. (2004). Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc Res 64: 105-114 [Abstract] [Full Text]  
  • Iwabu, A., Smith, K., Allen, F. D., Lauffenburger, D. A., Wells, A. (2004). Epidermal Growth Factor Induces Fibroblast Contractility and Motility via a Protein Kinase C {delta}-dependent Pathway. J. Biol. Chem. 279: 14551-14560 [Abstract] [Full Text]  
  • Glading, A., Bodnar, R. J., Reynolds, I. J., Shiraha, H., Satish, L., Potter, D. A., Blair, H. C., Wells, A. (2004). Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation. Mol. Cell. Biol. 24: 2499-2512 [Abstract] [Full Text]  
  • Suzuki, K., Hata, S., Kawabata, Y., Sorimachi, H. (2004). Structure, Activation, and Biology of Calpain. Diabetes 53: S12-18 [Abstract] [Full Text]  
  • Mamoune, A., Luo, J.-H., Lauffenburger, D. A., Wells, A. (2003). Calpain-2 as a Target for Limiting Prostate Cancer Invasion. Cancer Res. 63: 4632-4640 [Abstract] [Full Text]  
  • Wong, J. K., Le, H. H., Zsarnovszky, A., Belcher, S. M. (2003). Estrogens and ICI182,780 (Faslodex) Modulate Mitosis and Cell Death in Immature Cerebellar Neurons via Rapid Activation of p44/p42 Mitogen-Activated Protein Kinase. J. Neurosci. 23: 4984-4995 [Abstract] [Full Text]  
  • Crocker, S. J., Smith, P. D., Jackson-Lewis, V., Lamba, W. R., Hayley, S. P., Grimm, E., Callaghan, S. M., Slack, R. S., Melloni, E., Przedborski, S., Robertson, G. S., Anisman, H., Merali, Z., Park, D. S. (2003). Inhibition of Calpains Prevents Neuronal and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease. J. Neurosci. 23: 4081-4091 [Abstract] [Full Text]  
  • Gil-Parrado, S., Popp, O., Knoch, T. A., Zahler, S., Bestvater, F., Felgentrager, M., Holloschi, A., Fernandez-Montalvan, A., Auerswald, E. A., Fritz, H., Fuentes-Prior, P., Machleidt, W., Spiess, E. (2003). Subcellular Localization and in Vivo Subunit Interactions of Ubiquitous {micro}-Calpain. J. Biol. Chem. 278: 16336-16346 [Abstract] [Full Text]  
  • Seck, T., Baron, R., Horne, W. C. (2003). Binding of Filamin to the C-terminal Tail of the Calcitonin Receptor Controls Recycling. J. Biol. Chem. 278: 10408-10416 [Abstract] [Full Text]  
  • Becraft, P. W., Li, K., Dey, N., Asuncion-Crabb, Y. (2003). The maize dek1 gene functions in embryonic pattern formation and cell fate specification. Development 129: 5217-5225 [Abstract] [Full Text]